EPAS1 and cardiomyopathy: As mentioned previously, in studies of obesity‐related cardiomyopathy, activation of HIF‐2α in adipocytes leads to increased expression of inflammatory factors and chemokines that promote cardiac hypertrophy through activation of the NF‐κB and NFAT pathways in the heart [30].